Notably, approximately 70% of CTCs in both metastatic colorectal and breast cancers express the epithelial cell adhesion molecule (EPCAM), members of the Keratin (KRT) family, and/or vimentin (VIM) (Figure 2a,b). This evidence concerns the gene VIM and breast carcinoma.